TrialClinical and translational science2022

Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC-0214 in healthy volunteers.

Rui Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.